Although an increasing number of EGFR gene polymorphisms have been identified to play an important role in etiology of glioma and be significantly associated with glioma risk [10, 11, 16–24], no comprehensive study has been performed to detect the associations between these EGFR gene polymorphisms and glioma risk, and give us conclusive results. The gene discussed is EGFR; the disease is central nervous system cancer.